Medical Oncology

Stereotactic Body Radiotherapy

Questions discussed in this category

Would you offer adjuvant chemotherapy after SBRT for biopsy proven sub centimeter metastatic pulmonary nodule from rectal cancer?

1 Answer available

Would you offer SBRT to a biopsy proven T1 renal cell carcinoma on a transplanted kidney?

1 Answer available

How would you approach potential SBRT to liver metastases in a patient on a VEGF inhibitor?

Would you alter your SBRT dose? How long would you hold the VEGF inhibitor before and after? Does the primary matter (e.g. NSCLC vs. colorectal)?

1 Answer available

Is it safe to deliver SBRT to progressive lung metastases to patients with metastatic RCC receiving concurrent pazopanib?

2 Answers available

For T1b or T2a NSCLC cancer, approached with SABR, should chemotherapy be considered in the adjuvant setting?

As it is suggested for larger tumors treated with surgery, based on post hoc CALGB analysis?

2 Answers available

When is SBRT or hypofractionated radiation appropriate as adjuvant treatment for pancreatic cancer?

What are the targets (tumor bed, positive margin, nodes etc.)?

3 Answers available

When should SBRT be offered to oligometastatic bone disease in a patient with prostate cancer?

What factors should be considered with offering SBRT to oligometastatic bone disease in prostate cancer patients? Should this been done off of a proto...

2 Answers available

Papers discussed in this category

Cancer, 2007-11-15

Radiation therapy is associated with improved survival in patients with pancreatic adenocarcinoma: results of a study from the Surveillance, Epidemiology, and End Results (SEER) registry data.

Cancer, 2015-04-01

Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma.

JAMA, 2012 Jul 11

Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial.

JAMA, 2008-03-05

Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008-07-20

Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011-08-01

Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008-07-20

Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005).

International journal of radiation oncology, biology, physics, 2011-09-01

Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer.

American journal of clinical oncology, 2011-02

Stereotactic body radiotherapy in the treatment of advanced adenocarcinoma of the pancreas.

International journal of radiation oncology, biology, physics, 2013-12-01

Mapping patterns of local recurrence after pancreaticoduodenectomy for pancreatic adenocarcinoma: a new approach to adjuvant radiation field design.

JAMA, 2007 Jan 17

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.

Cancer, 1987 Jun 15

Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group.

Ann Surg, 2007 Nov

Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891.

Eur Urol, 2015 Jul 16

Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis.

BJU Int, 2009 Feb

Systemic therapy for advancing or metastatic prostate cancer (STAMPEDE): a multi-arm, multistage randomized controlled trial.

European urology, 2014-06

Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008-11-01

Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.

Semin Radiat Oncol, 2015 Oct

Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA.

Cancer, 2011-09-01

Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis.

International journal of radiation oncology, biology, physics, 2015-07-01

Gastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation Therapy.

Cancer treatment reviews, 2017-02

Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: A systematic review.

Strahlenther Onkol, 2019 Feb 08

Combination of stereotactic radiotherapy and targeted therapy: patterns-of-care survey in German-speaking countries.

Radiother Oncol, 2018 Jul 09

Stereotactic body radiotherapy for colorectal cancer liver metastases: A systematic review.

European urology focus, 2019-11

The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.

Medical Oncology

Stereotactic Body Radiotherapy

Questions discussed in this category

Papers discussed in this category

Related Topics in Medical Oncology